US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

NVIDIA Portfolio

1,781.21

-25.0525-1.39%

Number of Gainers:3

Number of Losers:5

Number of Flat:- -

PE:- -

High:1,851.35

Open:1,813.25

Low:1,775.86

Close:1,806.26

Loading ...

Weride Inc: Uber Technologies Has Committed to Equity Investment of US$100 Mln, in Addition to Its Existing Investment, in Weride

THOMSON REUTERS

China's Robotaxi Market May Grow to $12 Billion in 2030 -- Market Talk

Why Recursion Pharmaceuticals Stock Is Plummeting Today

Recursion Pharmaceuticals Inc : Bofa Global Research Cuts Price Objective to $8 From $10

THOMSON REUTERS

Recursion Pharmaceuticals (RXRX) Receives a Hold from TD Cowen

Uber, WeRide Expand Partnership to 15 More Cities

BRIEF-Uber And WeRide Expand Strategic Partnership To Bring Autonomous Vehicles To 15 More Cities

Uber :Co, Weride Expand Strategic Partnership to Bring Autonomous Vehicles to 15 Additional Cities Globally Over Next 5 Years, Including in Europe

THOMSON REUTERS

Uber and WeRide Expand Strategic Partnership to Bring Autonomous Vehicles to 15 More Cities

Shares of Recursion Pharmaceuticals Slide After 1Q Loss

Merit Medical Releases 12-Month Efficacy Results for the Single-Arm Arteriovenous Graft (AVG) Cohort of the WRAPSODY® Arteriovenous Efficacy (WAVE) Trial

Recursion Pharmaceuticals Shares Fall 3.9% Premarket After Q1 Results

THOMSON REUTERS

Recursion Pharmaceuticals Q1 EPS USD -0.5

THOMSON REUTERS

Spectrum Foods Arm Acquires Land to Develop Resort in Pushkar, India

MT Newswires Live

Recursion Pharmaceuticals Reports Promising Early Results for Familial Adenomatous Polyposis Drug Trial

MT Newswires Live

Recursion Pharmaceuticals Announces Promising Preliminary Results in Phase 1b/2 Trial of REC-4881 for Familial Adenomatous Polyposis

Preliminary Phase 1b/2 Data for REC-4881 in Familial Adenomatous Polyposis (FAP) Demonstrates Reduced Polyp Burden

Think SoundHound AI Is Expensive? These 3 Charts Might Change Your Mind.

Exchange Traded Funds Top 10 Percentage Gainers

Nebius Group files automatic mixed securities shelf

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/BK4609/news?page=3"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK4609","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4609\",,,,,undefined,":{"symbol":"BK4609","market":"US","secType":"PLATE","nameCN":"NVIDIA Portfolio","latestPrice":1781.2104,"timestamp":1746820799999,"preClose":1806.263,"halted":0,"volume":134511033,"delay":0,"changeRate":-0.01387,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Market Closed","change":-25.05249,"latestTime":"05-09 16:00:00 EDT","open":1813.2516,"high":1851.3477,"low":1775.8602,"amount":1772719100.141573,"amplitude":0.041792,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1747036800000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"pbRate":11.1161,"peRate":-96.237949,"turnoverRate":0.088807,"increases":3,"decrements":5,"flats":0,"marketCap":138325439264,"floatMarketCap":28244758048},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4609\",,,,,undefined,":{"symbol":"BK4609","high":1851.3477,"amplitude":0.041792,"preClose":1806.263,"low":1775.8602,"pbRate":"11.1161","latestPrice":1781.2104,"volume":134511033,"delay":0,"open":1813.2516,"prevYearClose":2189.1055,"prevWeekClose":1832.7129,"prevMonthClose":1703.1831,"prevQuarterClose":1599.8982,"fiveDayClose":1832.7129,"twentyDayClose":1518.8516,"sixtyDayClose":2529.7478,"secType":"PLATE","market":"US","turnoverRate":0.088807,"peRate":-96.237949,"marketCap":138325439264,"floatMarketCap":28244758048,"timestamp":1746820799999,"nameCN":"NVIDIA Portfolio"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK4609\",,,,undefined,":{"bkCode":"BK4609","up":3,"down":5,"flat":0},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK4609\",pageSize:20,pageCount:3,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2533007136","title":"Weride Inc: Uber Technologies Has Committed to Equity Investment of US$100 Mln, in Addition to Its Existing Investment, in Weride","url":"https://stock-news.laohu8.com/highlight/detail?id=2533007136","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533007136?lang=en_us&edition=fundamental","pubTime":"2025-05-07 18:49","pubTimestamp":1746614979,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250507:nFWN3RF1UW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU1983260115.SGD","GB00BDT5M118.USD","BK4230","LU0353189763.USD","SG9999014914.USD","SG9999018857.SGD","BK4535","BK4536","IE0002270589.USD","BK4505","SG9999014880.SGD","SGXZ31699556.SGD","LU0006306889.USD","LU1861214812.USD","BK4585","BK4503","LU0642271901.SGD","LU1814569148.SGD","SG9999014898.SGD","SG9999018865.SGD","BK4550","LU1988902786.USD","SG9999015978.USD","BK4609","SG9999015945.SGD","LU1316542783.SGD","LU0127658192.USD","LU0719512351.SGD","SG9999015986.USD","IE00B19Z3581.USD","LU2087625088.SGD","LU0082616367.USD","LU2360107325.USD","LU1861219969.SGD","BK4124","SG9999014906.USD","SG9999015952.SGD","LU0106261372.USD","LU1064131342.USD","BK4588","IE00BZ199S13.USD","UBER","BK4551","IE00BFMHRM44.USD","IE00B19Z3B42.SGD","LU0353189680.USD","WRD","SG9999017495.SGD","LU2264538146.SGD","IE00B7SZLL34.SGD"],"gpt_icon":0},{"id":"2533048642","title":"China's Robotaxi Market May Grow to $12 Billion in 2030 -- Market Talk","url":"https://stock-news.laohu8.com/highlight/detail?id=2533048642","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533048642?lang=en_us&edition=fundamental","pubTime":"2025-05-07 12:46","pubTimestamp":1746593160,"startTime":"0","endTime":"0","summary":"0446 GMT - China's robotaxi market is likely to grow to $12 billion in 2030 from $54 million this year, Goldman Sachs analysts write in a note. The total addressable market will grow hugely in the next decade, indicating a strong market opportunity, they say. Revenue mainly comes from fares and robotaxis could generate $69 per day by 2035, which would be higher than traditional ride-hailing vehicles, they say. China's total robotaxi fleet size will likely to rise to 0.5 million by 2030 from 4.1 thousand by 2025, they say. Existing players including Pony AI, WeRide, Baidu's Apollo will continue to be among the major players, thanks to high technological entry barriers and the leaders' advantages in algorithms, data, maps, among others.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","BK4609","BK4612","BK4531","BK4587","BK4574","BK4548","BK4543","BK4579","BK4535","BK4552","BK4514","BK4124","BK4504","LU0173614495.USD","LU0359201612.USD","BIDU","BK4602","LU1023057109.AUD","BK4023","LU1115378108.SGD","BK4614","BK4077","LU0287142896.SGD","IE00B0JY6N72.USD","BK4526","LU0359202008.SGD","LU0640798160.USD","BK4588"],"gpt_icon":1},{"id":"2533666175","title":"Why Recursion Pharmaceuticals Stock Is Plummeting Today","url":"https://stock-news.laohu8.com/highlight/detail?id=2533666175","media":"Motley Fool","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533666175?lang=en_us&edition=fundamental","pubTime":"2025-05-07 03:09","pubTimestamp":1746558540,"startTime":"0","endTime":"0","summary":"The results of a recent survey released Tuesday showed President Trump's actions are likely to make it harder for biotech companies like Recursion to raise capital.The company reported less-than-stellar earnings yesterday and announced it was ending the development of a significant portion of its pipeline.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com/investing/2025/05/06/why-recursion-pharmaceuticals-stock-is-plummeting/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"fool_stock","symbols":["BK4139","BK4609","BK4539","BK4611","RXRX","BK4548"],"gpt_icon":1},{"id":"2533846683","title":"Recursion Pharmaceuticals Inc : Bofa Global Research Cuts Price Objective to $8 From $10","url":"https://stock-news.laohu8.com/highlight/detail?id=2533846683","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533846683?lang=en_us&edition=fundamental","pubTime":"2025-05-06 18:48","pubTimestamp":1746528504,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250506:nFWN3RE1G2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4609","BK4548","BK4539","RXRX","BK4611","BK4139"],"gpt_icon":0},{"id":"2533648605","title":"Recursion Pharmaceuticals (RXRX) Receives a Hold from TD Cowen","url":"https://stock-news.laohu8.com/highlight/detail?id=2533648605","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533648605?lang=en_us&edition=fundamental","pubTime":"2025-05-06 05:55","pubTimestamp":1746482150,"startTime":"0","endTime":"0","summary":"In a report released today, Brendan Smith from TD Cowen maintained a Hold rating on Recursion Pharmaceuticals (RXRX – Research Report). The company...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/recursion-pharmaceuticals-rxrx-receives-a-hold-from-td-cowen-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/recursion-pharmaceuticals-rxrx-receives-a-hold-from-td-cowen-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","BK4548","COWN","BK4609","BK4611","BK4539","RXRX","TD","BK4139","BK4207","BK4127","BK4566"],"gpt_icon":0},{"id":"2533252569","title":"Uber, WeRide Expand Partnership to 15 More Cities","url":"https://stock-news.laohu8.com/highlight/detail?id=2533252569","media":"Dow Jones","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533252569?lang=en_us&edition=fundamental","pubTime":"2025-05-06 05:33","pubTimestamp":1746480780,"startTime":"0","endTime":"0","summary":"Uber Technologies and autonomous driving company WeRide have expanded their partnership to 15 additional cities over the next five years.The companies said Monday the partnership, which offers WeRide's Robotaxi services through the Uber app, will expand to several new cities each year, including those in Europe. All of the additional cities are outside of the U.S. and China.Uber will be responsible for fleet operations, the companies said.The expanded partnership follows a successful launch in Abu Dhabi and soon Dubai, and accelerates a shared goal of making autonomous mobility a reality around the world, the companies said.Shares of WeRide rose 21%, to $8.31, in after-hours trading on Monday. Uber shares traded flat.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"3b622d032cd82d0d162fd83b639a6829","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4124","LU0353189763.USD","LU2087625088.SGD","IE00BFMHRM44.USD","LU0106261372.USD","SG9999018865.SGD","LU0719512351.SGD","BK4505","WRD","IE00B7SZLL34.SGD","LU1861219969.SGD","LU0082616367.USD","SGXZ31699556.SGD","SG9999018857.SGD","BK4551","LU1861214812.USD","SG9999014898.SGD","BK4550","LU0642271901.SGD","BK4535","LU0006306889.USD","LU1316542783.SGD","LU2360107325.USD","SG9999015952.SGD","LU1064131342.USD","LU1814569148.SGD","UBER","BK4609","SG9999014880.SGD","SG9999017495.SGD","IE0002270589.USD","LU0127658192.USD","BK4503","BK4585","LU2264538146.SGD","SG9999015945.SGD","SG9999015986.USD","SG9999014914.USD","LU1983260115.SGD","LU0353189680.USD","BK4536","SG9999015978.USD","IE00BZ199S13.USD","IE00B19Z3581.USD","IE00B19Z3B42.SGD","LU1988902786.USD","BK4588","SG9999014906.USD","BK4022","GB00BDT5M118.USD"],"gpt_icon":1},{"id":"2533656916","title":"BRIEF-Uber And WeRide Expand Strategic Partnership To Bring Autonomous Vehicles To 15 More Cities","url":"https://stock-news.laohu8.com/highlight/detail?id=2533656916","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533656916?lang=en_us&edition=fundamental","pubTime":"2025-05-06 05:00","pubTimestamp":1746478801,"startTime":"0","endTime":"0","summary":"BRIEF-Uber And WeRide Expand Strategic Partnership To Bring Autonomous Vehicles To 15 More CitiesMay 5  - Uber Technologies Inc UBER.N:UBER :CO, WERIDE EXPAND STRATEGIC PARTNERSHIP TO BRING AUTONOMOUS VEHICLES TO 15 ADDITIONAL CITIES GLOBALLY OVER NEXT 5 YEARS, INCLUDING IN EUROPEFurther company coverage: UBER.N ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"4837c1660592fcce198b409cf9ccd562","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250505:nP8N3EN0CN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE0002270589.USD","IE00B19Z3B42.SGD","LU0642271901.SGD","SG9999015945.SGD","WRD","BK4551","IE00B7SZLL34.SGD","BK4230","BK4585","LU0719512351.SGD","BK4550","LU1983260115.SGD","UBER","SG9999017495.SGD","LU1064131342.USD","BK4535","IE00BZ199S13.USD","BK4588","SG9999015978.USD","SG9999018865.SGD","SG9999014914.USD","LU2360107325.USD","SG9999014906.USD","LU0353189680.USD","IE00B19Z3581.USD","LU0106261372.USD","BK4609","LU1861214812.USD","BK4536","LU2264538146.SGD","SG9999014880.SGD","BK4505","SG9999015986.USD","SG9999015952.SGD","LU1988902786.USD","GB00BDT5M118.USD","BK4124","LU1861219969.SGD","SG9999018857.SGD","BK4022","LU0127658192.USD","IE00BFMHRM44.USD","LU0353189763.USD","LU2087625088.SGD","LU0082616367.USD","SGXZ31699556.SGD","LU1316542783.SGD","LU1814569148.SGD","BK4503","LU0006306889.USD"],"gpt_icon":0},{"id":"2533421565","title":"Uber :Co, Weride Expand Strategic Partnership to Bring Autonomous Vehicles to 15 Additional Cities Globally Over Next 5 Years, Including in Europe","url":"https://stock-news.laohu8.com/highlight/detail?id=2533421565","media":"THOMSON REUTERS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533421565?lang=en_us&edition=fundamental","pubTime":"2025-05-06 05:00","pubTimestamp":1746478800,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"4837c1660592fcce198b409cf9ccd562","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250505:nP8N3EN0CN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0082616367.USD","LU1064131342.USD","SG9999015952.SGD","BK4550","SG9999017495.SGD","LU0106261372.USD","LU1988902786.USD","LU2087625088.SGD","SG9999015986.USD","IE0002270589.USD","LU0642271901.SGD","BK4124","BK4585","BK4551","IE00B19Z3B42.SGD","WRD","UBER","BK4536","BK4588","LU1861214812.USD","SG9999018857.SGD","SG9999014914.USD","IE00BZ199S13.USD","LU0006306889.USD","SG9999015945.SGD","LU0353189763.USD","SG9999014906.USD","BK4505","IE00B19Z3581.USD","GB00BDT5M118.USD","SG9999015978.USD","BK4230","BK4609","SG9999018865.SGD","LU1814569148.SGD","SG9999014880.SGD","BK4022","BK4503","LU0719512351.SGD","LU2264538146.SGD","LU1316542783.SGD","LU0353189680.USD","LU1861219969.SGD","LU1983260115.SGD","SG9999014898.SGD","IE00BFMHRM44.USD","LU0127658192.USD","BK4535","IE00B7SZLL34.SGD","LU2360107325.USD"],"gpt_icon":0},{"id":"2533044561","title":"Uber and WeRide Expand Strategic Partnership to Bring Autonomous Vehicles to 15 More Cities","url":"https://stock-news.laohu8.com/highlight/detail?id=2533044561","media":"Business Wire","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533044561?lang=en_us&edition=fundamental","pubTime":"2025-05-06 05:00","pubTimestamp":1746478800,"startTime":"0","endTime":"0","summary":"SAN FRANCISCO & GUANGZHOU, China, May 05, 2025----Uber Technologies, Inc. , the world’s largest mobility and delivery platform, and WeRide , a global leader in autonomous driving technology, today announced a significant expansion of their previously announced strategic partnership, adding 15 additional cities globally over the next five years, including in Europe. This expanded partnership accelerates WeRide and Uber’s shared goal of making autonomous mobility a global reality, with both companies leading the way in delivering cutting-edge technology.Following a successful launch in Abu Dhabi and soon Dubai, the companies have committed to expanding their autonomous vehicle partnership to several new cities each year, all outside of the US and China. In these cities, WeRide’s Robotaxi services will be available through the Uber app, and Uber will be responsible for fleet operations.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"4837c1660592fcce198b409cf9ccd562","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/uber-weride-expand-strategic-partnership-210000854.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU1064131342.USD","IE00B19Z3B42.SGD","LU2360107325.USD","SGXZ31699556.SGD","IE00B7SZLL34.SGD","SG9999015952.SGD","BK4503","LU1861219969.SGD","LU2087625088.SGD","IE00BFMHRM44.USD","BK4022","SG9999014880.SGD","BK4588","BK4230","SG9999014898.SGD","LU0719512351.SGD","BK4535","LU0006306889.USD","LU0353189680.USD","LU1814569148.SGD","LU0353189763.USD","SG9999014914.USD","BK4505","BK4550","LU1861214812.USD","IE00BZ199S13.USD","LU2264538146.SGD","LU1983260115.SGD","BK4609","BK4124","LU1316542783.SGD","BK4585","SG9999017495.SGD","GB00BDT5M118.USD","SG9999018857.SGD","LU0082616367.USD","BK4536","SG9999014906.USD","LU0106261372.USD","LU0127658192.USD","SG9999015945.SGD","IE0002270589.USD","SG9999018865.SGD","UBER","WRD","LU0642271901.SGD","SG9999015978.USD","BK4551","LU1988902786.USD","IE00B19Z3581.USD"],"gpt_icon":1},{"id":"2533371155","title":"Shares of Recursion Pharmaceuticals Slide After 1Q Loss","url":"https://stock-news.laohu8.com/highlight/detail?id=2533371155","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533371155?lang=en_us&edition=fundamental","pubTime":"2025-05-06 00:21","pubTimestamp":1746462060,"startTime":"0","endTime":"0","summary":"Shares of Recursion Pharmaceuticals fell after the company reported a first-quarter loss.Shares slid 13.4% to $4.94 during Monday's trading, and the stock is down 27% year to date.The clinical stage biotechnology company reported a first-quarter loss of $202.5 million, or 50 cents a share, compared with $91.4 million, or 39 cents a share, a year earlier.Analysts polled by FactSet were expecting a loss of 52 cents a share.Revenue grew to $14.7 million from $13.8 million during the year-ago quarter. Analysts were expecting $15 million.The Salt Lake City-based company said its research and development expenses rose to $130 million from $68 million during the year-ago quarter, driven primarily by an agreement with Tempus and a business combination with Exscientia.Recursion had a cash position of $509 million as of March 31, compared with $603 million on Dec. 31, 2024.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","RXRX","BK4139","BK4548","BK4611","BK4609"],"gpt_icon":1},{"id":"2533920580","title":"Merit Medical Releases 12-Month Efficacy Results for the Single-Arm Arteriovenous Graft (AVG) Cohort of the WRAPSODY® Arteriovenous Efficacy (WAVE) Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2533920580","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533920580?lang=en_us&edition=fundamental","pubTime":"2025-05-05 21:25","pubTimestamp":1746451500,"startTime":"0","endTime":"0","summary":"In the AVG cohort of the US pivotal trial, the Merit WRAPSODY Cell-Impermeable Endoprosthesis  achieved 60.2% target lesion primary patency  at 12 months.SOUTH JORDAN, Utah, May 05, 2025  -- Merit Medical Systems, Inc. , a global leader of healthcare technology, announced that the 12-month results from the single-arm cohort of the WAVE trial were presented at the annual Charing Cross Symposium held in London, England, on April 23, 2025, during the Vascular Access Masterclass session. Following the scientific podium presentation, results were presented during a Merit-sponsored symposium.ABOUT MERIT Founded in 1987, Merit Medical Systems, Inc. is engaged in the development, manufacture, and distribution of proprietary disposable medical devices used in interventional, diagnostic, and therapeutic procedures, particularly in cardiology, radiology, oncology, critical care, and endoscopy. Merit serves client hospitals worldwide with a domestic and international sales force and clinical suppo","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/merit-medical-releases-12-month-132500189.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["IE00BMPRXQ63.HKD","BK4141","BK4543","BK4133","BK4198","BK4588","MMSI","LU1559883803.SGD","BK4539","BK4585","IE00BMPRXN33.USD","BK4609","WAVE","LU0348723411.USD","LU0566484027.USD","IE00BMPRXR70.SGD"],"gpt_icon":1},{"id":"2533589134","title":"Recursion Pharmaceuticals Shares Fall 3.9% Premarket After Q1 Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2533589134","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533589134?lang=en_us&edition=fundamental","pubTime":"2025-05-05 20:32","pubTimestamp":1746448360,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250505:nL4N3RD0QK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4539","RXRX","BK4611","BK4139","BK4548","BK4609"],"gpt_icon":0},{"id":"2533042003","title":"Recursion Pharmaceuticals Q1 EPS USD -0.5","url":"https://stock-news.laohu8.com/highlight/detail?id=2533042003","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533042003?lang=en_us&edition=fundamental","pubTime":"2025-05-05 18:04","pubTimestamp":1746439446,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250505:nPLX528C70:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4609","BK4139","BK4548","RXRX","BK4539","BK4611"],"gpt_icon":0},{"id":"2533930575","title":"Spectrum Foods Arm Acquires Land to Develop Resort in Pushkar, India","url":"https://stock-news.laohu8.com/highlight/detail?id=2533930575","media":"MT Newswires Live","labels":["merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533930575?lang=en_us&edition=fundamental","pubTime":"2025-05-05 16:31","pubTimestamp":1746433897,"startTime":"0","endTime":"0","summary":"Spectrum Foods , through its subsidiary Siyana Resorts, completed the acquisition of a land parcel of 4,100 square yards situated at Pushkar in the Ajmer district of Rajasthan, India, according to a BSE filing on Monday.The company plans to use the acquired land to develop a boutique villa enclave.The company is already developing a 185-room five-star resort in Pushkar, which is in the final stages of construction and is expected to open shortly.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU2065732104.USD","SPB","BK4543","IE00BMPRXQ63.HKD","IE00BMPRXR70.SGD","BK4018","LU0348723411.USD","BK4141","BK4609","IE00BMPRXN33.USD","BK4588","BK4585"],"gpt_icon":1},{"id":"2533303765","title":"Recursion Pharmaceuticals Reports Promising Early Results for Familial Adenomatous Polyposis Drug Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2533303765","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533303765?lang=en_us&edition=fundamental","pubTime":"2025-05-05 16:10","pubTimestamp":1746432624,"startTime":"0","endTime":"0","summary":"Recursion Pharmaceuticals  said Sunday early results from a phase 1/2 trial of its drug REC-4881 for Familial Adenomatous Polyposis showed a median reduction in polyp burden of 43% after 13 weeks among six patients who were evaluated.The company said five patients saw polyp reductions between 31% and 82%, while one experienced a sharp increase compared to  20% to 30% reductions in other drugs over six months.Three patients also showed improvement in the Spigelman stage, while one worsened and two had mixed or unclear results.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4539","BK4139","BK4611","BK4609","BK4548","RXRX"],"gpt_icon":1},{"id":"2533324588","title":"Recursion Pharmaceuticals Announces Promising Preliminary Results in Phase 1b/2 Trial of REC-4881 for Familial Adenomatous Polyposis","url":"https://stock-news.laohu8.com/highlight/detail?id=2533324588","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533324588?lang=en_us&edition=fundamental","pubTime":"2025-05-05 00:45","pubTimestamp":1746377116,"startTime":"0","endTime":"0","summary":"Recursion Pharmaceuticals Announces Promising Preliminary Results in Phase 1b/2 Trial of REC-4881 for Familial Adenomatous Polyposis. Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Recursion Pharmaceuticals Inc. published the original content used to generate this news brief via GlobeNewswire  on May 04, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250504:nNDL4zwyhb:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4611","IE00B64PRP62.GBP","IE00BGHQF748.EUR","BK4548","RXRX","LU2210150020.SGD","IE00BKPKM429.USD","BK4139","BK4585","BK4539","BK4609","IE00B3QW5Z07.USD","LU2095319765.USD","BK4588","BK4112","LU2210149790.SGD","NDAQ"],"gpt_icon":1},{"id":"2533334128","title":"Preliminary Phase 1b/2 Data for REC-4881 in Familial Adenomatous Polyposis (FAP) Demonstrates Reduced Polyp Burden","url":"https://stock-news.laohu8.com/highlight/detail?id=2533334128","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533334128?lang=en_us&edition=fundamental","pubTime":"2025-05-05 00:45","pubTimestamp":1746377100,"startTime":"0","endTime":"0","summary":"In the Phase 2 open-label study, REC-4881  led to a median 43% reduction  in polyp burden at the Week 13 assessment at time of data cutoff.Five of six patients (83%) experienced reductions in polyp burden ranging from 31% to 82%, however, one patient showed a substantial increase from baseline.The early safety profile of REC-4881 was generally consistent with that of prior MEK1/2 inhibitors; among 19 patients across Phase 1b and 2, most treatment-related adverse events were Grade 1 or 2, with Grade 3 events in 16% of patients and no Grade ≥4 TRAEs reported to date.Across the combined Phase 1b and ongoing Phase 2 cohorts , REC-4881 demonstrated an early safety profile generally consistent with that of prior MEK1/2 inhibitors. Seventy-nine percent  of patients experienced at least one treatment-related adverse event , the majority of which were Grade 1 or 2 in severity. Grade 3 TRAEs occurred in 16% of patients, with no Grade ≥4 events reported to date. In Phase 1b, the","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/preliminary-phase-1b-2-data-164500686.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["TRAE","BK4218","PK","RXRX","BK4197","CPK","BK4611","BK4181","BK4539","REC","BK4609","BK4139","BK4548"],"gpt_icon":1},{"id":"2532539683","title":"Think SoundHound AI Is Expensive? These 3 Charts Might Change Your Mind.","url":"https://stock-news.laohu8.com/highlight/detail?id=2532539683","media":"Motley Fool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2532539683?lang=en_us&edition=fundamental","pubTime":"2025-05-03 23:37","pubTimestamp":1746286620,"startTime":"0","endTime":"0","summary":"This high growth could make shares cheap long-term.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com/investing/2025/05/03/think-soundhound-ai-is-expensive-this-chart-might/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"fool_stock","symbols":["BK4613","BK4547","SOUN","BK4609","BK4608","BK4023","BK4587"],"gpt_icon":1},{"id":"2532870807","title":"Exchange Traded Funds Top 10 Percentage Gainers","url":"https://stock-news.laohu8.com/highlight/detail?id=2532870807","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2532870807?lang=en_us&edition=fundamental","pubTime":"2025-05-03 05:40","pubTimestamp":1746222000,"startTime":"0","endTime":"0","summary":"Copyright (c) 2025 Dow Jones & Company, Inc.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4023","LU1861558580.USD","IE00BMPRXN33.USD","BK4585","BK4613","LU1861559042.SGD","IE00BMPRXR70.SGD","LU0348723411.USD","BK4609","IE00BMPRXQ63.HKD","PLTR","BK4547","BK4141","BK4543","BK4588"],"gpt_icon":1},{"id":"2532871287","title":"Nebius Group files automatic mixed securities shelf","url":"https://stock-news.laohu8.com/highlight/detail?id=2532871287","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2532871287?lang=en_us&edition=fundamental","pubTime":"2025-05-03 04:05","pubTimestamp":1746216321,"startTime":"0","endTime":"0","summary":"16:03 EDT Nebius Group (NBIS) files automatic mixed securities shelf Published first on TheFly – the ultimate source for real-time, market-moving b...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/nebius-group-files-automatic-mixed-securities-shelf?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/nebius-group-files-automatic-mixed-securities-shelf?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4077","LU0950373646.USD","LU0329931173.USD","LU0531971165.HKD","BK4097","LU0823431563.USD","LU0823431647.USD","BK4609","NBIS","LU0329931090.USD"],"gpt_icon":0}],"pageSize":20,"totalPage":5,"pageCount":3,"totalSize":91,"code":"91000000","status":"200"}]}}